Palbociclib and toremifene are anticancer drugs usually used to treat HER2-negative breast cancer and advanced breast cancer in postmenopausal women, respectively (Vogel et al., 2014; Mayer et al., 2021). The gene discussed is ERBB2; the disease is breast cancer.